Khan, S.; Aina, O.; Veneklasen, X.; Edens, H.; Alson, D.; Sun, L.; Zayed, H.; Njoya, K.; Sun, D.
The Combination of HSP90 Inhibitors and Selumetinib Reinforces the Inhibitory Effects on Plexiform Neurofibromas. Cancers 2025, 17, 2359.
https://doi.org/10.3390/cancers17142359
AMA Style
Khan S, Aina O, Veneklasen X, Edens H, Alson D, Sun L, Zayed H, Njoya K, Sun D.
The Combination of HSP90 Inhibitors and Selumetinib Reinforces the Inhibitory Effects on Plexiform Neurofibromas. Cancers. 2025; 17(14):2359.
https://doi.org/10.3390/cancers17142359
Chicago/Turabian Style
Khan, Sajjad, Oluwatosin Aina, Ximei Veneklasen, Hannah Edens, Donia Alson, Li Sun, Huda Zayed, Kimani Njoya, and Daochun Sun.
2025. "The Combination of HSP90 Inhibitors and Selumetinib Reinforces the Inhibitory Effects on Plexiform Neurofibromas" Cancers 17, no. 14: 2359.
https://doi.org/10.3390/cancers17142359
APA Style
Khan, S., Aina, O., Veneklasen, X., Edens, H., Alson, D., Sun, L., Zayed, H., Njoya, K., & Sun, D.
(2025). The Combination of HSP90 Inhibitors and Selumetinib Reinforces the Inhibitory Effects on Plexiform Neurofibromas. Cancers, 17(14), 2359.
https://doi.org/10.3390/cancers17142359
